CID 1387799

380882-30-4

Structural Information

Molecular Formula
C21H25N5O2S2
SMILES
CCN1CCN(CC1)C2=C(C(=O)N3C=CC=C(C3=N2)C)/C=C/4\C(=O)N(C(=S)S4)CC
InChI
InChI=1S/C21H25N5O2S2/c1-4-23-9-11-24(12-10-23)18-15(13-16-20(28)25(5-2)21(29)30-16)19(27)26-8-6-7-14(3)17(26)22-18/h6-8,13H,4-5,9-12H2,1-3H3/b16-13+
InChIKey
YFPKYYLWFFKOFW-DTQAZKPQSA-N
Compound name
(5E)-3-ethyl-5-[[2-(4-ethylpiperazin-1-yl)-9-methyl-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

443.14496 Da
Monoisotopic Mass

2.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 444.152236 206.7
[M+Na]+ 466.134178 216.5
[M-H]- 442.137684 210.3
[M+NH4]+ 461.178783 213.6
[M+K]+ 482.108118 207.1
[M+H-H2O]+ 426.142220 198.2
[M+HCOO]- 488.143161 208.3
[M+CH3COO]- 502.158811 213.3
[M+Na-2H]- 464.119626 199.2
[M]+ 443.14441142 207.4
[M]- 443.14550858 207.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.